Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
PCI Pharma Services
Sort By
Newest First
1 / 2
1 / 2
Digitalization
How can Life Science Technology Providers Support the Pharmaceutical Industry in the Transition Toward More Digitally Connected Operations?
Pharma's Almanac
PAO-06-24-RT-02
June 24, 2024
Investment
What are the Current Investment Trends in the Pharmaceutical Industry, and How are They Influencing the Sector’s Direction?
Pharma's Almanac
PAO-06-24-RT-01
June 24, 2024
Sterile Fill-Finish
PCI Pharma Services Begins Installation of Sterile Fill-Finish and Lyophilization Line as Part of $100 Million New Facility Expansion
PCI Pharma Services
PR-M05-24-01
May 02, 2024
ESG
Leading CDMO PCI Pharma Services Releases Inaugural Comprehensive ESG Report
PCI Pharma Services
PR-M03-24-04
March 27, 2024
Commitment to ESG Principles
How can pharmaceutical and biopharmaceutical companies demonstrate their commitment to ESG principles in manufacturing?
Pharma's Almanac
PAO-03-24-CL-03
March 08, 2024
Robotic Sterile Fill-Finish
Reducing Time to First-in-Human Trials with Robotic Sterile Fill-Finish Manufacturing Services
Peter Kim; Jerome Detreille; Derek Truninger
PAO-02-24-CL-03
February 14, 2024
Roundtable: Artificial Intelligence
In what areas of pharma/biopharma are you most excited to see increased adoption of artificial intelligence (AI) and machine learning?
Pharma's Almanac
PAO-07-23-RT-01
July 21, 2023
Roundtable: Patient Centricity
How is an increased focus on patient-centric concerns influencing the way that you work?
Pharma's Almanac
PAO-07-23-RT-02
July 21, 2023
International Markets
In what international markets do you anticipate significant developments in the near future?
Pharma's Almanac
PAO-01-23-RT-02
January 31, 2023
Disruptive Technology
What do you view as the most disruptive or transformational technology or development on the horizon?
Pharma's Almanac
PAO-01-23-RT-01
January 31, 2023
Controlled Substances in Clinical Trials
Controlled Substances in Clinical Trials: Considerations, Challenges, and Growing Demand
Rich Nelson; John Hufnagel; Rachel Castro
PCI Pharma Services
PAO-01-23-CL-03
January 30, 2023
Robotic Sterile Fill-Finish
Accelerating Drug Development Using Robotic Sterile Fill-Finish Platforms
Jeff Clement; Mark Shepanski
PCI Pharma Services
PAO-10-022-CL-09
November 11, 2022
Future of the Industry
What key indicators do you look at to predict the future of this industry?
Pharma's Almanac
PAO-10-022--RT-02
October 11, 2022
Sustainability
What is your plan to build a more sustainable business practice in the coming years?
Pharma's Almanac
PAO-10-022--RT-01
October 11, 2022
Unmet Needs
In which orphan spaces or unmet medical needs do you think we will see the next treatment innovations?
Pharma's Almanac
PAO-06-022--RT-01
June 24, 2022
Industry Challenges
What do you consider the biggest challenge that the pharma/biopharma industry currently faces?
Pharma's Almanac
O-06-022--RT-01
June 24, 2022
Capacity Expansion
PCI Pharma Services Announces Major Manufacturing Expansion with $100 Million Investment in New England, Providing Global Capacity to Clients
PCI Pharma Services
PR-M05-22-05
May 11, 2022
Leadership
Q: What’s the key to being a leader in the industry?
Pharma's Almanac
PAO-03-022-RT-02
March 11, 2022
Milestones
Q: What important company milestone do you anticipate reaching in 2022?
Pharma's Almanac
PAO-03-022-RT-01
March 11, 2022
Personalized and Precision Medicine
Q: What do you see as the key innovations or technologies that will make personalized/precision medicine a reality?
Pharma's Almanac
PAO-12-21-RT-01
January 07, 2022
